G6PC1 and type 2 diabetes mellitus: In type 2 diabetic mice, such as HFD/STZ-treated mice, the mRNA levels of hepatic PEPCK and G6Pase are elevated [25], and slight changes in the expression of these gluconeogenic genes can alter blood glucose levels [26].